Compare Medtronic PLC (MDT) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Medtronic PLC trades at $82.65 (market cap $106.61B), while Direxion Daily FTSE China Bull 3x Shares trades at $28.16. The key difference: Medtronic PLC pays a 3.46% dividend while Direxion Daily FTSE China Bull 3x Shares pays none. Which is the better fit depends on your goals.
| MDT | YINN | |
|---|---|---|
Market Cap | $106.61B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $56.62 |
52-Week Low | $73.75 | $21.45 |
Enterprise Value | $125.36B | — |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
YINN (Direxion Daily FTSE China Bull 3x ETF) trades at $28.89, up 7.84% with a bullish technical signal. The leveraged ETF structure amplifies exposure to Chinese equities, which face mixed sentiment amid economic stabilization efforts and US-China tensions. Moving averages show bullish momentum while oscillators remain neutral, with key resistance at $27.
Outlook remains volatile given YINN's 3x leverage structure and China's economic crosscurrents. Investment opportunity exists for tactical traders betting on China's infrastructure and AI stimulus, but risks include geopolitical friction and leveraged decay. The fund's performance hinges on Beijing's policy effectiveness versus US restrictions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
